Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Identification of Cancer Drivers at CTCF Insulators in 1,962 Whole Genomes.

Authors:
Eric Minwei Liu Alexander Martinez-Fundichely Bianca Jay Diaz Boaz Aronson Tawny Cuykendall Matthew MacKay Priyanka Dhingra Elissa W P Wong Ping Chi Effie Apostolou Neville E Sanjana Ekta Khurana

Cell Syst 2019 05 8;8(5):446-455.e8. Epub 2019 May 8.

Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10021, USA; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address:

Recent studies have shown that mutations at non-coding elements, such as promoters and enhancers, can act as cancer drivers. However, an important class of non-coding elements, namely CTCF insulators, has been overlooked in the previous driver analyses. We used insulator annotations from CTCF and cohesin ChIA-PET and analyzed somatic mutations in 1,962 whole genomes from 21 cancer types. Using the heterogeneous patterns of transcription-factor-motif disruption, functional impact, and recurrence of mutations, we developed a computational method that revealed 21 insulators showing signals of positive selection. In particular, mutations in an insulator in multiple cancer types, including 16% of melanoma samples, are associated with TGFB1 up-regulation. Using CRISPR-Cas9, we find that alterations at two of the most frequently mutated regions in this insulator increase cell growth by 40%-50%, supporting the role of this boundary element as a cancer driver. Thus, our study reveals several CTCF insulators as putative cancer drivers.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cels.2019.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917527PMC
May 2019

Publication Analysis

Top Keywords

cancer drivers
12
ctcf insulators
12
cancer types
8
non-coding elements
8
1962 genomes
8
cancer
5
selection mutations
4
positive selection
4
16% melanoma
4
signals positive
4
types including
4
mutations insulator
4
showing signals
4
including 16%
4
insulator multiple
4
multiple cancer
4
method revealed
4
transcription-factor-motif disruption
4
disruption functional
4
patterns transcription-factor-motif
4

Altmetric Statistics


Show full details
102 Total Shares
89 Tweets
89 Citations

Similar Publications

The tumor promotional role of adipocytes in the breast cancer micro- and macro-environment.

Authors:
Jamie Jenna Bernard Elizabeth Ann Wellberg

Am J Pathol 2021 Feb 24. Epub 2021 Feb 24.

Department of Pathology, Stephenson Cancer Center, and Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, USA. Electronic address:

The role of the adipocyte in the tumor microenvironment has received significant attention as a critical mediator of the obesity-cancer relationship. Thirteen cancers are considered obesity-associated, including breast cancer, and current estimates indicate that 650 million adults have obesity. Even in people with a normal body mass index (BMI), adipocytes are key players in breast cancer progression due to the proximity of tumors to mammary adipose tissue. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Quantifying 25 years of disease-caused declines in Tasmanian devil populations: host density drives spatial pathogen spread.

Authors:
Calum X Cunningham Sebastien Comte Hamish McCallum David G Hamilton Rodrigo Hamede Andrew Storfer Tracey Hollings Manuel Ruiz-Aravena Douglas H Kerlin Barry W Brook Greg Hocking Manna E Jones

Ecol Lett 2021 Feb 27. Epub 2021 Feb 27.

School of Natural Sciences, University of Tasmania, Private Bag 55, Hobart, TAS, 7001, Australia.

Infectious diseases are strong drivers of wildlife population dynamics, however, empirical analyses from the early stages of pathogen emergence are rare. Tasmanian devil facial tumour disease (DFTD), discovered in 1996, provides the opportunity to study an epizootic from its inception. We use a pattern-oriented diffusion simulation to model the spatial spread of DFTD across the species' range and quantify population effects by jointly modelling multiple streams of data spanning 35 years. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Activated ALK Cooperates with N-Myc via Wnt/β-catenin Signaling to Induce Neuroendocrine Prostate Cancer.

Authors:
Kenji Unno Zachary R Chalmers Sahithi Pamarthy Rajita Vatapalli Yara Rodriguez Barbara Lysy Hanlin Mok Vinay Sagar Huiying Han Young A Yoo Sheng-Yu Ku Himisha Beltran Yue Zhao Sarki A Abdulkadir

Cancer Res 2021 Feb 26. Epub 2021 Feb 26.

Urology, Northwestern University Feinberg School of Medicine

Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer with poor prognosis, and there is a critical need for novel therapeutic approaches. NEPC is associated with molecular perturbation of several pathways including amplification of MYCN. Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase involved in the pathogenesis of neuroblastoma and other malignancies where it cooperates with N-Myc. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

FAM83H-AS1 is a noncoding oncogenic driver and therapeutic target of lung adenocarcinoma.

Authors:
Siwei Wang Chencheng Han Tongyan Liu Zhifei Ma Mantang Qiu Jie Wang Qingjun You Xiufen Zheng Weizhang Xu Wenjia Xia Youtao Xu Jingwen Hu Lin Xu Rong Yin

Clin Transl Med 2021 Feb;11(2):e316

Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China.

Background: Little is known about noncoding oncogenes of lung adenocarcinoma (LUAD), and these potential drivers might provide novel therapeutic targets.

Methods: Since abnormally overexpression of oncogenic drivers is induced by genomic variation, we here utilized genomic, transcriptomic, and clinical prognosis data of The Cancer Genome Atlas (TCGA) LUAD datasets to discover novel drivers from long noncoding RNAs. We further used zebrafish models to validate the biological function of candidates in vivo. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Low dose pembrolizumab in the treatment of advanced non-small cell lung cancer.

Authors:
Jia Li Low Yiqing Huang Kenneth Sooi Yvonne Ang Zhi Yao Chan Katie Spencer Anand Devaprasath Jeyasekharan Raghav Sundar Boon Cher Goh Ross Soo Wei Peng Yong

Int J Cancer 2021 Feb 26. Epub 2021 Feb 26.

Department of Haematology-Oncology, National University Cancer Institute, Singapore.

A dose of 200mg 3-weekly of pembrolizumab was approved by the FDA as treatment for advanced NSCLC without oncogenic drivers. This is despite evidence showing no difference in efficacy with 2mg/kg. This study aimed to assess the efficacy of a lower fixed dose of 100mg, which is closer to 2mg/kg weight-based dose in an average sized Asian patient. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap